Next Century Growth Investors’s Pulmonx LUNG Stock Holding History

Next Century Growth Investors’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-454,614	Closed	-$7.57M	–	114
2022 Q3	$7.57M	Buy	454,614 +1,516	+0.3%	+$27.9K	0.92%	40
2022 Q2	$6.67M	Buy	453,098 +17,064	+4%	+$352K	0.87%	40
2022 Q1	$10.8M	Buy	436,034 +263,336	+152%	+$6.8M	1.08%	34
2021 Q4	$5.54M	Buy	172,698 +40,647	+31%	+$1.48M	0.5%	62
2021 Q3	$4.75M	Buy	+132,051	New	+$5.2M	0.41%	78
2021 Q1	–	Sell	-53,664	Closed	-$3.7M	–	134
2020 Q4	$3.7M	Buy	+53,664	New	+$2.63M	0.31%	92

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Next Century Growth Investors's LUNG Position: Q4 2022 in Review

Next Century Growth Investors sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 454,614 shares — an estimated $7.57M sold.

Next Century Growth Investors first reported a position in LUNG in Q4 2020 and held it in 6 quarters. The position peaked at $10.8M in Q1 2022. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

Next Century Growth Investors reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
Next Century Growth Investors sold 454,614 Pulmonx shares in Q4 2022, an estimated $7.57M.
Next Century Growth Investors first reported a position in Pulmonx in Q4 2020 and held it in 6 quarters.
Next Century Growth Investors's Pulmonx position peaked at $10.8M in Q1 2022.
116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Next Century Growth Investors's 13F filing for Q4 2022, filed 14 Feb 2023.